Barnett & Company, Inc. Novartis Ag Transaction History

Barnett & Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$81.78 - $95.14 $32,875 - $38,246	-402 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$70.67 - $99.01 $1,696 - $2,376	-24 Reduced 5.63%	402 $33,000
Q4 2019 Jan 22, 2020	BUY	$84.35 - $95.37 $33,908 - $38,338	402 Added 1675.0%	426 $40,000
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $2,052 - $2,262	24 New	24 $2,000
Q1 2019 Apr 26, 2019	SELL	$75.32 - $86.15 $44,664 - $51,086	-593 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$66.94 - $77.43 $39,695 - $45,915	593 New	593 $51,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.